MedTrace Logo

Treatment of CRF With Syndrome Differentiation of TCM

NCT04694755 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-01-06

No results posted yet for this study

Summary

Taking the patients with chronic respiratory failure caused by COPD as the research object and the acute exacerbation of COPD as the main outcome index, the investigators hope to establish the syndrome differentiation and treatment scheme of COPD treated by traditional Chinese medicine, reduce the acute exacerbation of AECOPD, improve the clinical symptoms, improve the quality of life, reduce the mortality, preliminarily explore the mechanism of action, and lay the foundation for further research.

Conditions

  • Chronic Respiratory Failure

Interventions

DRUG

Placebo

On the basis of dextrin and bitter agent, 5% of the drug was used to prepare.Its appearance, weight, color and smell are basically the same as traditional Chinese medicine granule.Tianjiang brand formula granules, in line with GMP standards

DRUG

Traditional Chinese medicine prescription

Tianjiang brand formula granules, in line with GMP standards

Sponsors & Collaborators

  • Henan University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Minghang Wang, doctor · The First Affiliated Hospital of Henan University of Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2022-05-31
Completion
2022-10-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04694755 on ClinicalTrials.gov